Adlai Nortye Ltd. American Depositary Shares
ANLStock
$11.35+509.27%52W
Market Cap$368.00M
P/E—
Div yield—
Beta1.42
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)521.46%
Price vs S&P 500 (4W)-18.40%
VGM Score61.29
Market Capitalization$368.00M
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.14
4.14
4.22
4.20
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
ANLAdlai Nortye Ltd. American Depositary Shares | — | — | B | $11.35 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Adlai Nortye Ltd is a clinical-stage biotech company developing cancer therapies targeting multiple tumor types. The company's pipeline comprises three clinical-stage drug candidates and three preclinical assets.